American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$510M |
| 2 |
ExxonMobil
XOM
|
+$222M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
CRH
CRH
|
+$189M |
| 5 |
Meta Platforms (Facebook)
META
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$387M |
| 2 |
Colgate-Palmolive
CL
|
+$242M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$183M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
2626
DELISTED
Inozyme Pharma
INZY
| $255K | ﹤0.01% |
57,100
+5,673
| +11% | +$27.5K |
|
2627
Papa John's
PZZA
$804M
| $253K | ﹤0.01% |
5,386
+827
| +18% | +$45.3K |
|
2628
AerSale
ASLE
$273M
| $252K | ﹤0.01% |
36,480
+4,134
| +13% | +$29.6K |
|
2629
Norwood Financial Corp
NWFL
$376M
| $251K | ﹤0.01% |
9,871
-376
| -4% | -$9.31K |
|
2630
FRP Holdings
FRPH
$425M
| $250K | ﹤0.01% |
+8,779
| New | +$263K |
|
|
SRG
2631
Seritage Growth Properties
SRG
$128M
| $250K | ﹤0.01% |
53,468
+5,519
| +12% | +$40.1K |
|
2632
Valhi
VHI
$466M
| $249K | ﹤0.01% |
13,983
-93
| -0.7% | -$1.59K |
|
|
CHCT
2633
Community Healthcare Trust
CHCT
$433M
| $249K | ﹤0.01% |
10,625
+552
| +5% | +$13.4K |
|
|
HLVX
2634
DELISTED
HilleVax
HLVX
| $248K | ﹤0.01% |
17,158
+1
| +0% | +$14 |
|
|
EPIX
2635
DELISTED
ESSA Pharma
EPIX
| $246K | ﹤0.01% |
46,748
+572
| +1% | +$3.64K |
|
2636
Sight Sciences
SGHT
$458M
| $240K | ﹤0.01% |
35,948
+8,527
| +31% | +$50.4K |
|
2637
Donegal Group Class A
DGICA
$696M
| $237K | ﹤0.01% |
18,416
-88
| -0.5% | -$1.17K |
|
2638
Janux Therapeutics
JANX
$978M
| $236K | ﹤0.01% |
5,627
-21,428
| -79% | -$1.01M |
|
|
SIX
2639
DELISTED
Six Flags Entertainment Corp.
SIX
| $234K | ﹤0.01% |
7,058
-20,532
| -74% | -$541K |
|
2640
Xenon Pharmaceuticals
XENE
$6.21B
| $233K | ﹤0.01% |
5,979
-3,676
| -38% | -$147K |
|
2641
XPeng
XPEV
$11.3B
| $233K | ﹤0.01% |
31,797
| – | – |
|
2642
Holley
HLLY
$362M
| $230K | ﹤0.01% |
64,383
+12,186
| +23% | +$47.5K |
|
2643
Asure Software
ASUR
$251M
| $228K | ﹤0.01% |
27,145
+4,756
| +21% | +$35.9K |
|
2644
Dyne Therapeutics
DYN
$4.85B
| $228K | ﹤0.01% |
+6,451
| New | +$187K |
|
|
NVRO
2645
DELISTED
NEVRO CORP.
NVRO
| $227K | ﹤0.01% |
27,011
+1,907
| +8% | +$20.3K |
|
2646
Alector
ALEC
$228M
| $227K | ﹤0.01% |
50,083
-21,346
| -30% | -$110K |
|
2647
IonQ
IONQ
$18.2B
| $222K | ﹤0.01% |
31,604
| – | – |
|
|
SKYT
2648
DELISTED
SkyWater Technology
SKYT
| $219K | ﹤0.01% |
28,651
-4,187
| -13% | -$36.3K |
|
2649
Richardson Electronics
RELL
$300M
| $218K | ﹤0.01% |
18,372
+2,359
| +15% | +$25.1K |
|
2650
BrightSpring Health Services
BTSG
$11.9B
| $216K | ﹤0.01% |
+19,029
| New | +$208K |
|
Similar funds
American Century Companies's Q2 2024 Portfolio in Review
As of Q2 2024, American Century Companies held 3,009 positions worth $163B, up 2.7% from $159B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q2 2024 filing shows 89 new, 1,863 increased, 760 reduced and 131 closed positions. Its largest new stake was UL Solutions: 1,631,475 shares worth $68.8M. The largest sale was UnitedHealth, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2024 buy was UL Solutions: 1,631,475 shares worth $68.8M.
- American Century Companies added most to iShares Russell 1000 Growth ETF in Q2 2024, an estimated $510M increase.
- American Century Companies's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $387M.
- American Century Companies fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $235M.
- American Century Companies's ten largest holdings make up 27% of its $163B portfolio in Q2 2024.
- American Century Companies opened 89 new positions and closed 131 in Q2 2024.
- American Century Companies's portfolio value rose 2.7% quarter-over-quarter to $163B.
Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.